Skip to main content

Bruker Revenues Down on Currency Translation

NEW YORK (GenomeWeb News) – Bruker today reported a 3 percent decline in first-quarter revenues, due primarily to negative currency effects, as the firm swung to a profit from a loss.

The Billerica, Mass.-based maker of mass spectrometers and other scientific research tools, brought in revenues of $230.5 million for the three-month period ended March 31, compared to $238.3 million for the first quarter of 2008. Its product revenues were $202.2 million versus $208.3 million the year before, while its service revenues were $26.9 million, down from $28.7 million in Q1 2008. Its "other" revenues were $1.4 million versus $1.3 million the year before.

Bruker posted a profit of $8.6 million, or $.05 per share, compared to a net loss of $600,000, or $.00 per share, for the first quarter of 2008. Its results from Q1 2008 included a $5.8 million charge related to acquisitions, compared to no such charge in Q1 2009.

Bruker's R&D expenses decreased 7 percent to $29.1 million from $31.2 million, while its SG&A spending increased 16 percent to $59.3 million from $51.2 million.

"While certain industrial and pharma market segments this year are even more challenging than we had expected, our non-profit, governmental and other healthcare orders remain strong," said Bruker President and CEO Frank Laukien in a statement. "For example, we are excited about our double-digit order growth in life-science mass spectrometry, driven by the compelling capabilities of our high-performance products. We also see positive signs as a result of the various international government stimulus packages, which in our opinion will particularly benefit high-end research equipment."

Bruker finished the quarter with $149.9 million in cash, short-term investments, and restricted cash.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.